{"id":"https://openalex.org/W4396947104","doi":"https://doi.org/10.1097/01.aog.0001013744.92674.8b","title":"Buprenorphine Dosing Through the Pregnancy-to-Postpartum Transition: A Descriptive Analysis [ID 2683589]","display_name":"Buprenorphine Dosing Through the Pregnancy-to-Postpartum Transition: A Descriptive Analysis [ID 2683589]","publication_year":2024,"publication_date":"2024-05-01","ids":{"openalex":"https://openalex.org/W4396947104","doi":"https://doi.org/10.1097/01.aog.0001013744.92674.8b"},"language":"en","primary_location":{"id":"doi:10.1097/01.aog.0001013744.92674.8b","doi":"https://doi.org/10.1097/01.aog.0001013744.92674.8b","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aog.0001013744.92674.8b","pdf_url":null,"source":{"id":"https://openalex.org/S139838620","display_name":"Obstetrics and Gynecology","issn_l":"0029-7844","issn":["0029-7844","1873-233X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obstetrics & Gynecology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036208580","display_name":"Caroline R. Shadowen","orcid":"https://orcid.org/0009-0007-1124-830X","observed_orcids":["https://orcid.org/0009-0007-1124-830X"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caroline R. Shadowen","raw_affiliation_strings":["Virginia Commonwealth University, Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Commonwealth University, Richmond, VA","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088447524","display_name":"Hannah M. Shadowen","orcid":"https://orcid.org/0000-0003-1939-7311","observed_orcids":["https://orcid.org/0000-0003-1939-7311"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hannah Shadowen","raw_affiliation_strings":["Virginia Commonwealth University, Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Commonwealth University, Richmond, VA","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093242425","display_name":"Lillia Thumma","orcid":"https://orcid.org/0009-0008-0715-7808","observed_orcids":["https://orcid.org/0009-0008-0715-7808"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lillia Thuma","raw_affiliation_strings":["Virginia Commonwealth University, Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Commonwealth University, Richmond, VA","institution_ids":["https://openalex.org/I184840846"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032682110","display_name":"Caitlin Eileen Martin","orcid":"https://orcid.org/0000-0001-5560-458X","observed_orcids":["https://orcid.org/0000-0001-5560-458X"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caitlin E. Martin","raw_affiliation_strings":["Virginia Commonwealth University, Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Commonwealth University, Richmond, VA","institution_ids":["https://openalex.org/I184840846"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I184840846"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.07057564,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"143","issue":"5S","first_page":"57S","last_page":"58S"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11633","display_name":"Prenatal Substance Exposure Effects","score":0.027300000190734863,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.9620000123977661},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pregnancy","display_name":"pregnancy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/postpartum-period","display_name":"postpartum period","score":0.9760000109672546},{"id":"https://openalex.org/keywords/drug-dosage","display_name":"drug dosing","score":0.6119999885559082},{"id":"https://openalex.org/keywords/dose-changes","display_name":"dose changes","score":0.39899998903274536},{"id":"https://openalex.org/keywords/incarceration","display_name":"incarceration","score":0.32899999618530273},{"id":"https://openalex.org/keywords/mode-of-delivery","display_name":"mode of delivery","score":0.9039999842643738},{"id":"https://openalex.org/keywords/cesarean-section","display_name":"cesarean section","score":0.8510000109672546},{"id":"https://openalex.org/keywords/shared-decision-making","display_name":"shared decision-making","score":0.8690000176429749},{"id":"https://openalex.org/keywords/decision-aids","display_name":"decision aids","score":0.6819999814033508},{"id":"https://openalex.org/keywords/maternal-health","display_name":"maternal health","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8303897380828857},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.8030825853347778},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.5824140310287476},{"id":"https://openalex.org/C131872663","wikidata":"https://www.wikidata.org/wiki/Q5284418","display_name":"Obstetrics","level":1,"score":0.5702413320541382},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47848910093307495},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3782038390636444},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3697965741157532},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1554960310459137},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.13671809434890747},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12988349795341492},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.aog.0001013744.92674.8b","doi":"https://doi.org/10.1097/01.aog.0001013744.92674.8b","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.aog.0001013744.92674.8b","pdf_url":null,"source":{"id":"https://openalex.org/S139838620","display_name":"Obstetrics and Gynecology","issn_l":"0029-7844","issn":["0029-7844","1873-233X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obstetrics & Gynecology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7138346012","https://openalex.org/W3045817028","https://openalex.org/W2035561650","https://openalex.org/W4405107021","https://openalex.org/W4394855339","https://openalex.org/W3153963415","https://openalex.org/W3158546570","https://openalex.org/W4388568260","https://openalex.org/W4391056889","https://openalex.org/W7204957249"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Supporting":[1],"continuation":[2],"of":[3,59,65,168,178,186,195,221],"life-saving":[4],"medications":[5],"for":[6,218,224],"opioid":[7],"use":[8,231],"disorder":[9],"(OUD),":[10],"like":[11],"buprenorphine":[12],"(BUP),":[13],"is":[14,55],"imperative":[15],"through":[16,149],"the":[17,39,128,155,215,219,248],"postpartum":[18,43,152,225],"period.":[19],"However,":[20],"no":[21,119],"clinical":[22,51],"guidelines":[23],"exist":[24],"to":[25,230,234,239],"inform":[26,235],"BUP":[27,35,78,90,103,133,147,222,244],"dosing":[28,223],"in":[29,38,48,102,132,213,247],"this":[30],"transition.":[31,250],"Our":[32,206],"study":[33,64,207],"describes":[34],"dose":[36,104,164,245],"changes":[37,131,246],"first":[40,211],"3":[41,94,108,150],"months":[42,95,151],"and":[44,83,87,107,135],"associated":[45],"patient":[46,136],"characteristics":[47],"an":[49,60,73],"OUD":[50,69],"sample.":[52],"METHODS:":[53],"This":[54],"a":[56,110,209,236],"secondary":[57],"analysis":[58,126],"IRB-approved":[61],"retrospective":[62],"cohort":[63],"pregnant":[66],"patients":[67,157,169,179,187,196],"with":[68,113],"who":[70,188,197],"delivered":[71,189,198],"at":[72,92,171],"academic":[74],"medical":[75,123],"center,":[76],"initiated":[77],"between":[79,105,130],"January":[80],"1,":[81],"2018,":[82],"March":[84],"30,":[85],"2020,":[86],"remained":[88],"on":[89],"until":[91],"least":[93],"postpartum.":[96],"The":[97],"primary":[98],"outcome":[99],"was":[100],"change":[101],"delivery":[106,172],"months:":[109],"categorical":[111],"variable":[112],"three":[114],"levels":[115],"(increase,":[116],"decrease,":[117],"or":[118,161],"change)":[120],"abstracted":[121],"from":[122],"record.":[124],"Bivariate":[125],"assessed":[127],"relationship":[129],"dosage":[134,148],"characteristics.":[137],"RESULTS:":[138],"In":[139],"our":[140],"sample":[141],"(N=66),":[142],"about":[143,243],"half":[144],"maintained":[145],"their":[146,163,174,183,192,203],"(n=36;":[153],"55%);":[154],"remaining":[156],"decreased":[158,191,202],"(n=22;":[159],"33%)":[160],"increased":[162,173,182],"(n=8;":[165],"12%).":[166],"38%":[167],"incarcerated":[170,181],"dose,":[175],"whereas":[176],"9%":[177],"not":[180],"dose.":[184,204],"39%":[185],"vaginally":[190],"dose;":[193],"24%":[194],"via":[199],"cesarean":[200],"section":[201],"CONCLUSION:":[205],"takes":[208],"crucial":[210],"step":[212],"developing":[214],"evidence":[216],"base":[217],"individualization":[220],"people.":[226],"Ultimately,":[227],"we":[228],"aim":[229],"these":[232],"data":[233],"decision":[237],"aid":[238],"facilitate":[240],"shared":[241],"decision-making":[242],"pregnancy-to-postpartum":[249]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2024-05-17T00:00:00"}